Abnormal neutrophil chemotactic activity in children with congenital insensitivity to pain with anhidrosis (CIPA): The role of nerve growth factor

Clinical Immunology

Volumn 130, Issue 3, 2009, Pages 365-372

  Beigelman, Avraham ^a   Levy, Jacov ^a   Hadad, Nurit ^a   Pinsk, Vered ^a   Haim, Alon ^a   Fruchtman, Yariv ^a   Levy, Rachel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Chemotaxis; CIPA; Neutrophils

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE;

ANHIDROSIS; ARTICLE; AUTOMUTILATION; BACTERIAL ARTHRITIS; CHILD; CLINICAL ARTICLE; CONGENITAL INSENSITIVITY TO PAIN WITH ANHIDROSIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FEVER; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LACERATION; MALE; MENTAL DEFICIENCY; NEUROPATHY; NEUTROPHIL CHEMOTAXIS; OSTEOMYELITIS; PARESTHESIA; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; CHEMOKINES; CHEMOTAXIS; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; FEMALE; HUMANS; HYPOHIDROSIS; INFANT; MALE; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUTROPHILS; PAIN INSENSITIVITY, CONGENITAL; YOUNG ADULT;

EID: 59449087887     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.09.005     Document Type: Article

References (28)

1. Rosenberg S., Marie S.K., and Kliemann S. Congenital insensitivity to pain with anhidrosis (hereditary sensory neuropathy type IV). Pediatr. Neurol. 11 (1994) 50-52
2. Sztrina L., Lestringant G.G., Hertecant J., Frossard P.M., and Masouye I. Congenital insensitivity to pain with anhidrosis. Pediatr. Neurol. 25 (2001) 63-66
3. Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin. Auton. Res. 12 Suppl 1 (2002) I20-I32
4. Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum. Mutat. 18 (2001) 462-471
5. Greco A., Villa R., Tubino B., Romano L., Penso D., and Pierotti M.A. A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis. Am. J. Hum. Genet. 64 (1999) 1207-1210
6. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237 (1987) 1154-1162
7. Bonini S., Rasi G., Bracci-Laudiero M.L., Procoli A., and Aloe L. Nerve growth factor: neurotrophin or cytokine?. Int. Arch. Allergy Immunol. 131 (2003) 80-84
8. Foster P.A., Wicks S., Foster M., and Brain S.D. Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: neutrophil-dependent and -independent events. J. Pathol. 197 (2002) 245-255
9. Gee A.P., Boyle M.D., Munger K.L., Lawman M.J., and Young M. Nerve growth factor: stimulation of polymorphonuclears leukocyte chemotaxis in vitro. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 7215-7218
10. Shatzky S., Moses S., Levy J., Pinsk V., Hershkovitz E., Herzog L., Shorer Z., Luder A., and Parvari R. Congenital insensitivity to pain with anhydrosis (CIPA) in Israeli Bedouins: genetics heterogeneity, novel mutation in the TRK\NGF receptor gene, clinical findings, and results of nerve conduction studies. Am. J. Med. Genet. 92 (2000) 353-360
11. Levy R., Malech H.L., and Rotrosen D. Production of myeloid cell cytosols functionally and immunochemically deficient in the 47 kDa or 67 kDa NADPH oxidase cytosolic factors. Biochem. Biophys. Res. Commun. 170 (1990) 1114-1119
12. Liel Y., Rudich A., Nagauker O., Yermiyahu T., and Levy R. Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation. Blood 83 (1994) 2646-2653
13. Levy R., Rotrosen D., Nagauker O., Leto T.L., and Malech H.L. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J. Immunol. 145 (1990) 2595-2599
14. Hazan-Halevy I., Zeger R., and Levy R. The requirement of both ERK and p38 MAP-kinase for stimulation of cytosolic phospholipase A2 activity by either FcgammaRIIA or FcgammaRIIIB in human neutrophils. A possible role of Pyk2 but not the Grb2-Sos-Shc complex. J. Biol. Chem. 275 (2000) 12416-12423
15. Arraes S.M., Freitas M.S., da Silva S.V., de Paula Neto H.A., Alves-Filho J.C., Auxiliadora Martins M., Basile-Filho A., Tavares-Murta B.M., Barja-Fidalgo C., and Cunha F.Q. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 108 (2006) 2906-2913
16. Angeles T.S., Yang S.X., Steffler C., and Dionne C.A. Kinetics of trkA tyrosine kinase activity and inhibition by K-252a. Arch. Biochem. Biophys. 349 (1998) 267-274
17. Kohyama T., Liu X., Wen F.Q., Kobayashi T., Abe S., Ertl R., and Rennard S.I. Nerve growth factor stimulates fibronectin-induced fibroblast migration. J. Lab. Clin. Med. 140 (2002) 329-335
18. Micera A., Vigneti E., Pickholtz D., Reich R., Pappo O., Bonini S., Maquart F.X., Aloe L., and Levi-Schaffer F. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6162-6167
19. Kannan Y., Ushio H., Koyama H., Okada M., Oikawa M., Yoshihara T., Kaneko M., and Matsuda H. 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 77 (1991) 1320-1325
20. la Sala A., Corinti S., Federici M., Saragovi H.U., and Girolomoni G. Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. J. Leukoc. Biol. 68 (2000) 104-110
21. Ehrhard P.B., Erb P., Graumann U., Schmutz B., and Otten U. Expression of functional trk tyrosine kinase receptors after T cell activation. J. Immunol. 152 (1994) 2705-2709
22. Lambiase A., Bracci-Laudiero L., Bonini S., Starace G., D'Elios M.M., De Carli M., and Aloe L. Human CD4+T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy. Clin. Immunol. 100 (1997) 408-414
23. Melamed I., Levy J., Parvari R., and Gelfand E.W. A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA). J. Clin. Immunol. 24 (2004) 441-448
24. Oda M., Ikari S., Matsuno T., Morimune Y., Nagahama M., and Sakurai J. Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils. Infect. Immun. 74 (2006) 2876-2886
25. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10 (2000) 381-391
26. Sawada J., Itakura A., Tanaka A., Furusaka T., and Matsuda H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood 95 (2000) 2052-2058
27. Bokoch G.M. Chemoattractant signaling and leukocyte activation. Blood 86 (1995) 1649-1660
28. Kuan Y.H., Lin R.H., Chen Y.L., Tsao L.T., Tzeng C.C., and Wang J.P. Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway. Biochem. Pharmacol. 72 (2006) 749-760